Oncology & Cancer

Latest vaccine study supports immune targeting of brain tumors

An experimental vaccine developed by researchers at Cedars-Sinai Medical Center's Maxine Dunitz Neurosurgical Institute targets overactive antigens in highly aggressive brain tumors and improves length of survival in newly ...

page 2 from 2